Krustev, E., Hanly, J. G., Chin, R., Buhler, K. A., Urowitz, M. B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sánchez-Guerrero, J., Bernatsky, S., Wallace, D. J., Isenberg, D., Rahman, A., Merrill, J. T., Fortin, P. R., Gladman, D. D., Bruce, I. N., Petri, M. A., Ginzler, E. M., … Choi, M. Y. (2024). Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus Science & Medicine, 11(1), e001139. https://doi.org/10.1136/lupus-2023-001139

Adeuyan, O., Magro, C. M., Trager, M. H., Gordon, E. R., Lapolla, B. A., Schreidah, C. M., Fahmy, L. M., & Geskin, L. J. (2024). Plasma cell and neutrophil enriched neovascularization with granulomatous lymphangitis in POEMS syndrome. JAAD Case Reports, 49, 125–128. https://doi.org/10.1016/j.jdcr.2024.03.025

Nishiyama, S., Seok, J. M., Wright, A. E., Lotan, I., Mikami, T., Drosu, N. C., Bobrowski-Khoury, N., Anderson, M. R., Bilodeau, P. A., Schindler, P., Paul, F., Aoki, M., Yeaman, M. R., Levy, M., Behne, J. M., Behne, M. K., Bennett, J. L., Blaschke, T. F., … Chitnis, T. (2024). Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-53661-5

Tarragon Estebanez, B., & Bomback, A. S. (2024). C3 Glomerulopathy: Novel Treatment Paradigms. Kidney International Reports, 9(3), 569–579. https://doi.org/10.1016/j.ekir.2023.12.007

Ugarte-Gil, M. F., Hanly, J., Urowitz, M., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A. E., Wallace, D. J., Isenberg, D. A., Rahman, A., Merrill, J. T., Fortin, P. R., Gladman, D. D., Bruce, I. N., Petri, M., Ginzler, E. M., Dooley, M. A., … Alarcón, G. S. (2022). Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the Rheumatic Diseases, 81(11), 1541–1548. https://doi.org/10.1136/ard-2022-222487

Almeida-Brasil, C. C., Hanly, J. G., Urowitz, M., Clarke, A. E., Ruiz-Irastorza, G., Gordon, C., Ramsey-Goldman, R., Petri, M., Ginzler, E. M., Wallace, D. J., Bae, S.-C., Romero-Diaz, J., Dooley, M. A., Peschken, C., Isenberg, D., Rahman, A., Manzi, S., Jacobsen, S., Lim, S., … Bernatsky, S. (2022). Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the Rheumatic Diseases, 81(3), 370–378. https://doi.org/10.1136/annrheumdis-2021-221295

Attarian, S., Young, P., Brannagan, T. H., Adams, D., Van Damme, P., Thomas, F. P., Casanovas, C., Kafaie, J., Tard, C., Walter, M. C., Péréon, Y., Walk, D., Stino, A., de Visser, M., Verhamme, C., Amato, A., Carter, G., Magy, L., Statland, J. M., & Felice, K. (2021). A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A. Orphanet Journal of Rare Diseases, 16(1). https://doi.org/10.1186/s13023-021-02040-8

Askanase, A. D., Wright, D., Zhao, E., Zhu, J., Bilyk, R., & Furie, R. A. (2021). Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus. Rheumatology and Therapy, 8(4), 1871–1886. https://doi.org/10.1007/s40744-021-00351-7